Cite
0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial
MLA
Renate Le Marsney, et al. “0.9% Sodium Chloride Solution versus Plasma-Lyte 148 versus Compound Sodium LacTate Solution in Children Admitted to PICU—a Randomized Controlled Trial (SPLYT-P): Study Protocol for an Intravenous Fluid Therapy Trial.” Trials, vol. 22, no. 1, July 2021, pp. 1–10. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....933e5ebbcd626c7964495b62732c5189&authtype=sso&custid=ns315887.
APA
Renate Le Marsney, Kristen Gibbons, Luregn J. Schlapbach, Sainath Raman, Andreas Schibler, Melanie Kennedy, Adrian C. Mattke, & Peter Trnka. (2021). 0.9% Sodium chloride solution versus Plasma-Lyte 148 versus compound sodium lacTate solution in children admitted to PICU—a randomized controlled trial (SPLYT-P): study protocol for an intravenous fluid therapy trial. Trials, 22(1), 1–10.
Chicago
Renate Le Marsney, Kristen Gibbons, Luregn J. Schlapbach, Sainath Raman, Andreas Schibler, Melanie Kennedy, Adrian C. Mattke, and Peter Trnka. 2021. “0.9% Sodium Chloride Solution versus Plasma-Lyte 148 versus Compound Sodium LacTate Solution in Children Admitted to PICU—a Randomized Controlled Trial (SPLYT-P): Study Protocol for an Intravenous Fluid Therapy Trial.” Trials 22 (1): 1–10. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....933e5ebbcd626c7964495b62732c5189&authtype=sso&custid=ns315887.